Nick Lydon, Ph.D. discovered and co-developed the leukemia drug Gleevec. In this discussion, which is part of the Frontiers In Cancer Research series of talks at UC Santa Barbara, Lydon talks about the scientific process of discovering this drug and how it was tested to determine its effectiveness in battling leukemia.
The legal battle that had been waged by the Abigail Alliance since 2003 ended abruptly on January 14 when the Supreme Court refused to hear the appeal by the patient advocates. Currently, it is illegal [...]
In case you were wondering what our philosophy is on finding a cure for GIST, this video sums it up quite nicely. Listen and enjoy.
Fuqua doesn’t talk about it often. He doesn’t bring it up unless asked, and even then he offers only a brief explanation. He fears he’ll be known more for his illness than his accomplishments, even when his achievements place him among the top track athletes in the state and in the Lawrence High record book.
In last month’s newsletter, the Life Raft Group published its study on the effects of imatinib dose upon the survival of metastatic GIST patients. On February 4, we also held a webcast, “The Link Between [...]
Concerns raised, FDA meets on ESAs. Concerns raised, FDA meets on ESAs. Erythropoetin stimulating agents (ESAs) promote the production of red blood cells by red blood stem cells.
The doctor is in: common patient questions answered